These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 14677181

  • 1. Pentoxifylline in the treatment of refractory nephrotic syndrome secondary to lupus nephritis.
    Galindo-Rodríguez G, Bustamante R, Esquivel-Nava G, Salazar-Exaire D, Vela-Ojeda J, Vadillo-Buenfil M, Aviña-Zubieta JA.
    J Rheumatol; 2003 Nov; 30(11):2382-4. PubMed ID: 14677181
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
    De Bandt M, Goycochea MV, Meyer O, Delahousse M, Palazzo E, M'Bappé P, Kahn MF.
    Ann Med Interne (Paris); 1994 Nov; 145(2):75-87. PubMed ID: 8024184
    [Abstract] [Full Text] [Related]

  • 4. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [Abstract] [Full Text] [Related]

  • 5. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 6. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
    Morović-Vergles J, Galesić K, Dancuo I, Vergles D.
    Acta Med Croatica; 2004 Sep; 58(1):13-7. PubMed ID: 15125388
    [Abstract] [Full Text] [Related]

  • 7. [The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis].
    Ianushkevich TN, Klepikov PV.
    Ter Arkh; 1990 Sep; 62(6):50-3. PubMed ID: 2218927
    [Abstract] [Full Text] [Related]

  • 8. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X, Club Rhumatismes et Inflammation.
    Arthritis Res Ther; 2005 Sep; 7(3):R545-51. PubMed ID: 15899041
    [Abstract] [Full Text] [Related]

  • 9. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression.
    Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S, Lai KN.
    Lupus; 1999 Sep; 8(7):545-51. PubMed ID: 10483033
    [Abstract] [Full Text] [Related]

  • 10. Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis.
    Christopher-Stine L, Petri M, Astor BC, Fine D.
    J Rheumatol; 2004 Aug; 31(8):1557-9. PubMed ID: 15290735
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
    Aringer M, Graninger WB, Steiner G, Smolen JS.
    Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
    [Abstract] [Full Text] [Related]

  • 12. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M, Saiz A, Fernández-Reyes MJ, Sánchez R, Zurita P, Urrego C.
    Nefrologia; 2011 Oct; 31(2):231-3. PubMed ID: 21461001
    [No Abstract] [Full Text] [Related]

  • 13. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage.
    Funauchi M, Ikoma S, Imada A, Kanamaru A.
    J Clin Lab Immunol; 1997 Oct; 49(2):47-57. PubMed ID: 9819673
    [Abstract] [Full Text] [Related]

  • 14. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [Abstract] [Full Text] [Related]

  • 15. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
    Yee CS, Gordon C, Dostal C, Petera P, Dadoniene J, Griffiths B, Rozman B, Isenberg DA, Sturfelt G, Nived O, Turney JH, Venalis A, Adu D, Smolen JS, Emery P.
    Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
    [Abstract] [Full Text] [Related]

  • 16. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK.
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [Abstract] [Full Text] [Related]

  • 18. [Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].
    Frutos MA, Martín Gómez A, de Ramón E, Camps MT, Valera A, García I, Fernández Nebro A.
    Nefrologia; 2007 Nov; 27(1):12-22. PubMed ID: 17402875
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
    Illei GG, Yarboro CH, Kuroiwa T, Schlimgen R, Austin HA, Tisdale JF, Chitkara P, Fleisher T, Klippel JH, Balow JE, Boumpas DT.
    Rheumatology (Oxford); 2007 Jun; 46(6):952-6. PubMed ID: 17317716
    [Abstract] [Full Text] [Related]

  • 20. Outcome of lupus nephritis in Indian children.
    Hari P, Bagga A, Mahajan P, Dinda A.
    Lupus; 2009 Apr; 18(4):348-54. PubMed ID: 19276303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.